AzTrials
AzTrials

Newborn; FitNCT06900127

The Effects Of Safe Swadding On Newborns' Oxygen Saturation And Comfort Level

A study testing Safe Swaddling in people with Newborn; Fit and Safety Issues, run by Ayse Sonay Turkmen, Prof.Dr at 2 sites in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Objective: This study was conducted as a randomized controlled experimental study to determine the effects of safe swaddling on oxygen saturation and comfort in preterm newborns born between 30-36 weeks of gestation. Read more about this study

Who is it for?
Ages 1 day to 60 daysHealthy volunteers can take part
Conditions the study is for
Newborn; Fit, Safety Issues
What is being tested?
Safe Swaddling
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
2 sitesTurkey (Türkiye)
Study dates
14 Mar 2024to 1 Mar 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 60 days
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • The baby's gestational age to be between 30 weeks and 36 weeks,
  • The baby's birth weight to be 1250 grams or more,
  • The baby's oxygen requirement to be 40% or less,
  • The baby's to be between 4-28 days old,
  • The swaddling to be done by the same nurse,
  • Parents must agree to participate in the study.

Who cannot join

  • • In our study, the babies were not followed up during the first 72 hours because of possible interventions such as giving them surfactant, exposing them to more invasive procedures, and taking heel blood resulting fluctuations in their vital signs.
  • The baby's having any kind of congenital anomalies.
  • There being a situation that prevents swaddling.
  • Criteria for dropping from the study while the study is ongoing
  • When the baby loses his/her life,
  • When the family gives up participating in the study,
  • When the baby is intubated.

Trial locations and contacts

2 sites in 1 country.

Turkey (Türkiye)2 sites
  • Ayşe Sonay Türkmen

    Karaman, 70100

  • Karamanoglu Mehmetbey University

    Karaman

Other trials in Turkey (Türkiye)

About this study

Objective: This study was conducted as a randomized controlled experimental study to determine the effects of safe swaddling on oxygen saturation and comfort in preterm newborns born between 30-36 weeks of gestation.

Methods: The sample of the study consisted of 70 newborns (Safe swaddling group =35, control group=35) hospitalized in the neonatal intensive care unit of a university hospital in Türkiye. The preterm newborns in the safe swaddling group were monitored by applying the safe swaddling method outside of care hours (12:00, 18:00, 24:00, 06:00), while those in the control group were followed in accordance with the hospital routines. An information form and a newborn comfort behavior scale were used as data collection tools. Descriptive statistics, chi-square, t test, Anova, analysis of variance in repeated measures, and Tukey forward analysis were used to evaluate the data.

Read the detailed description

The population of the study consisted of preterm newborns receiving treatment in the Tertiary Neonatal Intensive Care Unit of X University Medical Faculty Hospital. Preterm babies between 30-36 weeks of gestation were included in the sample. The sample size of the study was accepted as type 1 error probability (α) 0.05 (95% confidence level) and type 2 error probability (β) 0.10 (80% power level), taking into account the known score in the G*Power 3.1.5 program. The sample size was determined as 32 for each group. However, since it was thought that there might be loss during the analysis, it was planned to reach 35 newborns for each group. As a result of the study, a total of 70 preterm newborns who met the inclusion criteria were reached.

Randomization The distribution of the newborns included in the study into groups was created by a statistician using codes obtained from a permutation-based computer program and stratified according to gestational age. The groups represented by the letters were determined at the beginning of the study using the closed opaque envelope method. As a result of the draw, it was decided that the letter A would represent the control group, and the letter B would represent the safe swaddling group. A single-participant blinding was applied in the study. A separate informed consent form was created and approved for each group. Thus, each newborn parent received information only about the intervention that would be applied to him/her. Randomization was followed according to the CONSORT 2010 diagram.

Hypotheses H1: Safe swaddling applied to preterm newborns has an effect on mean comfort scores.

H2: Safe swaddling applied to preterm newborns has an effect on oxygen saturation.

Data Collection Tools The study data were collected using the Information Form, Neonatal Comfort Behavior Scale (COMFORTneo), Neonatal Bedside Monitor, and Histogram Tracking Form.

Information form 10 questions containing introductory information in the information form (age, gender, delivery method, birth order, height and weight, etc.) consist of a question determining the status of special care and a newborn follow-up chart (daily oxygen saturation, comfort score, behavioral response status, and pain).

Newborn Comfort Behavior Scale (COMFORTneo) The scale is a Likert-type scale developed to assess the need for sedation and comfort, pain, and distress of newborns monitored in intensive care.

Neonatal bedside monitor The SpO2 data of the newborn taken with the bedside monitor were obtained from Philips IntelliVue MP40 model monitors in 24-hour periods. This monitor was preferred because it has a histogram feature. Data is stored in the monitor as 24-hour oxygen saturation trends.

Histogram tracking form In the Neonatal Intensive Care Unit, SpO2 monitoring is recorded via monitors and expressed as a percentage. The percentages of histogram data obtained through monitors are recorded. According to the histogram saturation evaluation results, preterm newborns received oxygen support as per clinical practice. The method of oxygen support given varies depending on the needs of the preterm newborn. Therefore, newborns whose 24-hour saturation trend is below 20% in the undesirable range (1-90%) in the histogram evaluation are considered hypoxia and therefore immediate intervention is required. Oxygen support is applied as NIMV (NCPAP, AIRVO, HF, LF, respectively) and free flow.

Data collection For the control group, safe swaddling was not applied, and routine hospital care and treatments were continued. The newborn's comfort assessment was made by two observers using the Neonatal Comfort Behavior Scale (COMFORTneo) every day at 10:00 during the data collection period. Histogram measurements were also taken by the researcher at 10:00 as a 24-hour oxygen saturation record. The newborn's height, weight, feeding frequency and amount were taken by the researcher every day at 10:00 during the data collection period and recorded on the data collection form. As for the safe swaddling group: safe swaddling was applied to the newborn by the researcher at the beginning of the study. Safe swaddling was applied after the newborn completed the 72nd hour after birth. The swaddle was removed only during care hours, for an average of 20 minutes. The newborn was then swaddled again by the same researcher. Since there are four care hours per day in the hospital routine, this total duration was accepted as 80 minutes. The newborn's comfort assessment was made by two observers using the Newborn Comfort Behavior Scale (COMFORTneo) every day at 10:00 during the data collection period. Histogram measurements were also taken by the researcher at 10:00 as a 24-hour oxygen saturation record. The newborn's height, weight, feeding frequency and amount were taken by the researcher every day at 10:00 during the data collection period and recorded on the data collection form.

Evaluation of Data The data obtained were evaluated in the computer environment using descriptive statistics (number, percentage, mean, standard deviation, min-max values), chi-square, t-test, Anova, analysis of variance in repeated measures, and Tukey advanced analysis in the SPSS 21 package program.

Ethical Aspects of the Study The study was carried out in accordance with the ethical principles at every stage. Before implementing the study, ethical permission was obtained from the Non-Interventional Research Ethics Committee of X University Faculty of Health Sciences (dated 31.03.2021, numbered 01-2021/05) and institutional permission was obtained from X University Medical Faculty Hospital (dated 25.06.2021 and numbered E-30292447-045.99-91265). Written consent was obtained from parents who met the criteria to be included in the study on a voluntary basis.

Being tested
Safe Swaddling
Keywords
Safe Swaddling, Comfort; Saturation, Newborn

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Safe SwaddlingBehavioural

    newborns will be wrapped with the safe wrapping method.

Study groups in NCT06900127
Study groupRoleWhat they receive
Safe SwaddlingExperimentalNot described
Receives: Behavioral: Safe Swaddling
control groupNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. comfort

    comfort score averages

    Measured: once a day until discharged (up to 60 days) Min.=6 points, Max.=30 points

  2. oxygen saturation

    daily oxygen saturation averages

    Measured: every day until discharge (up to 60 days)

Secondary outcomes (2)
  1. NCPAP

    Number of days receiving NCPAP

    Measured: every day until discharge (up to 60 days)

  2. hospitalization

    days of hospitalization

    Measured: every day until discharge (up to 60 days)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Mar 2025
  2. Study start14 Mar 2024
  3. Primary completion15 Aug 2024
  4. Study completion1 Mar 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06900127
Sponsor's protocol ID
Safe Swaddling
Status last verified
Apr 2025
First submitted
14 Mar 2025
Last updated
18 Apr 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Safe Swaddling in people with Newborn; Fit and Safety Issues, run by Ayse Sonay Turkmen, Prof.Dr at 2 sites in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

comfort (time frame: once a day until discharged (up to 60 days) Min.=6 points, Max.=30 points). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in